These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 6233249

  • 41. In-vitro activity of pefloxacin compared with six other quinolones.
    Ligtvoet EE, Wickerhoff-Minoggio T.
    J Antimicrob Chemother; 1985 Oct; 16(4):485-90. PubMed ID: 3864776
    [Abstract] [Full Text] [Related]

  • 42. Comparison of the in vitro activity of ciprofloxacin (Bay o 9867) and norfloxacin against gastrointestinal tract pathogens.
    Diez-Enciso M, Mas-Jimenez G, Velasco-Cerrudo A, Gutierrez-Altes A.
    Eur J Clin Microbiol; 1984 Aug; 3(4):367. PubMed ID: 6237905
    [No Abstract] [Full Text] [Related]

  • 43. Activity of ciprofloxacin against resistant clinical isolates.
    Kelley SG, Bertram MA, Young LS.
    J Antimicrob Chemother; 1986 Mar; 17(3):281-6. PubMed ID: 2939048
    [Abstract] [Full Text] [Related]

  • 44. [In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
    Grimm H.
    Arzneimittelforschung; 1985 Mar; 35(3):570-2. PubMed ID: 2986655
    [Abstract] [Full Text] [Related]

  • 45. Norfloxacin: in vitro activity compared with that of seven other antibacterial agents against urinary tract pathogens.
    Digranes A, Dibb WL, Ostervold B.
    Acta Pathol Microbiol Immunol Scand B; 1984 Apr; 92(2):101-6. PubMed ID: 6233841
    [Abstract] [Full Text] [Related]

  • 46. The in vitro and in vivo activity of ciprofloxacin.
    Zeiler HJ, Grohe K.
    Eur J Clin Microbiol; 1984 Aug; 3(4):339-43. PubMed ID: 6237902
    [Abstract] [Full Text] [Related]

  • 47. In vitro activity of ciprofloxacin against group JK corynebacteria.
    Machka K, Balg H.
    Eur J Clin Microbiol; 1984 Aug; 3(4):375. PubMed ID: 6237907
    [No Abstract] [Full Text] [Related]

  • 48. Ciprofloxacin (BAY O 9867). Comparative in vitro activity study.
    Canton E, Garcia J, Vila B, Santos M, Gobernado M.
    Microbiol Esp; 1984 Aug; 37(3-4):73-9. PubMed ID: 6242123
    [No Abstract] [Full Text] [Related]

  • 49. In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.
    Wise R, Andrews JM, Danks G.
    J Antimicrob Chemother; 1984 Mar; 13(3):237-44. PubMed ID: 6586712
    [Abstract] [Full Text] [Related]

  • 50. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D, O'Hare MD, Robbins MJ, Wall RA, Williams AH, Cremer AW, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Mar; 11(5):317-29. PubMed ID: 2941259
    [Abstract] [Full Text] [Related]

  • 51. Mutational resistance to 4-quinolone antibacterial agents.
    Smith JT.
    Eur J Clin Microbiol; 1984 Aug; 3(4):347-50. PubMed ID: 6237904
    [Abstract] [Full Text] [Related]

  • 52. Frequency of appearance of resistant variants to norfloxacin and nalidixic acid.
    Duckworth GJ, Williams JD.
    J Antimicrob Chemother; 1984 May; 13 Suppl B():33-8. PubMed ID: 6234273
    [Abstract] [Full Text] [Related]

  • 53. In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.
    Peeters M, Van Dyck E, Piot P.
    Antimicrob Agents Chemother; 1984 Oct; 26(4):608-9. PubMed ID: 6240224
    [Abstract] [Full Text] [Related]

  • 54. The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin.
    King A, Shannon K, Phillips I.
    J Antimicrob Chemother; 1985 May; 15(5):551-8. PubMed ID: 3159712
    [Abstract] [Full Text] [Related]

  • 55. Antibacterial activity of norfloxacin.
    Norrby SR, Jonsson M.
    Antimicrob Agents Chemother; 1983 Jan; 23(1):15-8. PubMed ID: 6219617
    [Abstract] [Full Text] [Related]

  • 56. In vitro antibacterial activity of three new quinolone derivatives: rosoxacin, norfloxacin, pefloxacin.
    Husson MO, Izard D, Leclerc H.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(2-3):283-6. PubMed ID: 6241772
    [Abstract] [Full Text] [Related]

  • 57. The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones.
    Neu HC.
    J Antimicrob Chemother; 1985 Jul; 16(1):43-8. PubMed ID: 3862659
    [Abstract] [Full Text] [Related]

  • 58. In vitro antibacterial activity of norfloxacin and other agents against ocular pathogens.
    Shungu DL, Tutlane VK, Weinberg E, Gadebusch HH.
    Chemotherapy; 1985 Jul; 31(2):112-8. PubMed ID: 3157551
    [Abstract] [Full Text] [Related]

  • 59. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
    Ridgway GL, O'Hare MD, Felmingham D, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Jul; 11(4):259-62. PubMed ID: 2941258
    [Abstract] [Full Text] [Related]

  • 60. In vitro activity of enoxacin compared with norfloxacin and amikacin.
    van der Auwera P, de Moor G, Lacroix G, Mambour A, Rossion N, Schuyteneer F.
    Eur J Clin Microbiol; 1985 Feb; 4(1):55-8. PubMed ID: 3157568
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.